Contact
Please use this form to send email to PR contact of this press release:
First-In-Human Study of Immbio’s Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
TO:
Please use this form to send email to PR contact of this press release:
First-In-Human Study of Immbio’s Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
TO: